Premium
Posterior leukoencephalopathy following cisplatin, bleomycin and vinblastine therapy for germ cell tumor of the ovary
Author(s) -
Sueblinvong Thanasak,
Noophun Phadet,
Pataradool Kamol,
Suwanwela Nitaya,
Phanthumchinda Kammant,
Tresukosol Damrong
Publication year - 2002
Publication title -
journal of obstetrics and gynaecology research
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.597
H-Index - 50
eISSN - 1447-0756
pISSN - 1341-8076
DOI - 10.1046/j.1341-8076.2002.00018.x
Subject(s) - medicine , bleomycin , vinblastine , cisplatin , chemotherapy , germ cell tumors , leukoencephalopathy , cyclophosphamide , complication , magnetic resonance imaging , combination chemotherapy , surgery , oncology , radiology
A 31‐year‐old female developed multiple episodes of grand mal seizures after combination chemotherapy with cisplatin, vinblastine and bleomycin for germ cell ovarian cancer stage Ic. The clinicoradiologic fea‐tures in this patient were consistent with posterior leukoencephalopathy, which is a rare complication of chemotherapy. Seizures were controlled by the anticonvulsive agent Dilantin (Pfizer, Khet Klongtoey, Bangkok) and she returned home without any permanent neurologic deficits. Follow‐up magnetic resonance imaging 2 weeks later showed complete resolution of the abnormalities. This syndrome has been previously reported following cisplatin‐based chemotherapy. Physicians should remain alert to the potential hazards of chemotherapy to the central nervous system. Risks and benefits should be seriously considered before starting treatment.